Rekombinanter ITGA4 (Natalizumab Biosimilar) Antikörper

Produktnummer ABIN5668197

Produktdetails anti-ITGA4 (Natalizumab Biosimilar) Antikörper

Target: ITGA4 (Natalizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Chimeric

Konjugat: Dieser ITGA4 (Natalizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Blocking Reagent (BR)

Spezifität: This antibody binds to the alpha 4 binds subunit of α4β1 (also known as very late antigen 4 [VLA-4] or CD49d-CD29) and α4β7 integrin

Produktmerkmale:

OriginalSpeciesName: Human

OriginalFormat: IgG4

Aufreinigung: Purified antibody.

Reinheit: > 98 % as determined by SDS-PAGE

Endotoxin-Niveau: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: The RAMOS cell line, a non-EBV releasing cell line, injected into mice.

Isotyp: IgG kappa

Anwendungsinformationen

Applikationshinweise: This antibody binds to human integrin alpha 4 and has been used to treat Multiple Sclerosis and Crohn's Disease.

Kommentare:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu ITGA4 (Natalizumab Biosimilar)

Target: ITGA4 (Natalizumab Biosimilar)

Abstract: ITGA4 (Natalizumab Biosimilar) Produkte

Synonyme: CD49D antikoerper, IA4 antikoerper, integrin subunit alpha 4 antikoerper, ITGA4 antikoerper

Hintergrund: CD49D, alpha 4 subunit of VLA-4 receptor, ITGA4, Integrin alpha-IV

UniProt: P13612